Tallink Grupp
AS Tallink Grupp will introduce the results of the fourth quarter of 2020 in an investor webinar. All shareholders and other stakeholders are invited to join the webinar, scheduled to take place on 25 February 2021 at 15:00 (EET). The webinar will be held in English and prior registration is required.
The financial results will be presented by the Chairman of the Management Board Paavo Nõgene and Financial director Joonas Joost. We kindly ask participants to provide their questions before the webinar, latest by 12:00 on 25 February, by e-mail to: investor@tallink.ee. Due to time constraint, preference will be given to questions submitted in writing before the webinar.
How to join the webinar?
To join the webinar, please register by 25 February 2020 at 14:30 (EET) latest via the following link: https://attendee.gotowebinar.com/register/6429824564915167504.
When joining the webinar for the first time, you will be asked to download the plug-in which will only take a few seconds. In case the plug-in cannot be downloaded, a web browser which enables attending the webinar, will open automatically.
Registered participants will receive a reminder e-mail one hour prior to the webinar. The webinar will be recorded and will be available online for everyone on the company’s website at www.tallink.com/investors/webinars and on the Nasdaq Baltic youtube.com account.
Joonas Joost
Financial director
AS Tallink Grupp
Sadama 5
10111 Tallinn, Estonia
E-mail joonas.joost@tallink.ee
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Zealand Pharma18.7.2025 18:30:00 CEST | Press release
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
SpringWorks Therapeutics, Inc.18.7.2025 17:30:40 CEST | Press release
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
Photocat A/S18.7.2025 17:00:00 CEST | Press release
PHOTOCAT has today applied for a transfer of its trading venue from Nasdaq First North Growth Market to Spotlight Stock Market.
Golden Ocean Group Limited18.7.2025 16:30:00 CEST | Press release
GOGL – Notice of Special General Meeting
Kapitalforeningen SDG Invest18.7.2025 16:06:31 CEST | Pressemeddelelse
Kapitalforeningen SDG Invest - Opdateret prospekt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom